Ask AI

JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps

The treatment landscape for alopecia areata is shifting with the recent FDA approval of two JAK inhibitors and a robust development pipeline. Join us for this multiactivity program to hear the latest insights about pathophysiology, diagnosis, management, and much more from renowned dermatology experts.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

National Alopecia Areata Foundation

ProCE Banner

In partnership with the National Alopecia Areata Foundation.